The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease

Neuroscience Bulletin

Volumn 27, Issue 5, 2011, Pages 287-299

  Xiao, Ai Wu ^a   He, Jing ^a   Wang, Qian ^a,b   Luo, Yi ^a   Sun, Yan ^a   Zhou, Yan Ping ^a   Guan, Yang ^c   Lucassen, Paul J ^b   Dai, Jia Pei ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Axonopathy; Neurofibrillary tangles; Postmortem tracing; Senile plaques

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHY; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; SWELLING; VARICOSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AXONAL TRANSPORT; AXONS; BRAIN; CASE-CONTROL STUDIES; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROANATOMICAL TRACT-TRACING TECHNIQUES; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; POSTMORTEM CHANGES; REFERENCE VALUES; TAU PROTEINS; TEMPORAL LOBE; TISSUE BANKS;

EID: 81355141965     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-011-1736-7     Document Type: Article

References (42)

1. Masliah E, Mallory M, Deerinck T, DeTeresa R, Lamont S, Miller A, et al. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol 1993, 52: 619-632. (Pubitemid 23335738)
2. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993, 16: 460-465. (Pubitemid 23313524)
3. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991, 12: 383-388.
4. Armstrong RA, Myers D, Smith CUM. The spatial patterns of plaques and tangles in Alzheimer's disease do not support the 'Cascade hypothesis'. Dementia 1993, 4: 16-20. (Pubitemid 23071253)
5. Terry RD. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996, 55: 1023-1025. (Pubitemid 26338013)
6. Neve RL, Robakis NK. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci 1998, 21: 15-19. (Pubitemid 128766369)
7. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297: 353-356. (Pubitemid 34790756)
8. Mudher A, Lovestone S. Alzheimer's disease-do tauists and bap tists finally shake hands? Trends Neurosci 2002, 25: 22-26. (Pubitemid 34093781)
9. Duyckaerts C. Looking for the link between plaques and tangles. Neurobiol Aging 2004, 25: 735-739. (Pubitemid 38698246)
10. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004, 430: 631-639. (Pubitemid 39061671)
11. Schonheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004, 25: 697-711. (Pubitemid 38698241)
12. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120: 545-555. (Pubitemid 40269768)
13. Trojanowski JQ, Lee VMY. The Alzheimer's brain binding out what's broken tells us how to fix it. Am J Pathol 2005, 167: 1183-1188. (Pubitemid 41541405)
14. Armstrong RA. The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis". Int J Alzheimers Dis 2011, 2011: 630865.
15. Schwartz JH. Axonal transport: components, mechanisms, and specificity. Annu Rev Neurosci 1979, 2: 467-504.
16. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 1998, 279: 519-526. (Pubitemid 28067273)
17. Dai J, Buijs RM, Kamphorst W, Swaab DF. Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes. Brain Res 2002, 948: 138-144. (Pubitemid 35283771)
18. Dai J, Buijs RM, Swaab DF. Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease. Br J Pharmacol 2004, 143: 606-610. (Pubitemid 39524278)
19. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307: 1282-1288. (Pubitemid 40299973)
20. Stokin GB, Goldstein LS. Axonal transport and Alzheimer's disease. Annu Rev Biochem 2006, 75: 607-627. (Pubitemid 44118045)
21. Smith KD, Kallhoff V, Zheng H, Pautler RG. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35: 1401-1408. (Pubitemid 46561352)
22. Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, et al. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's diseaselinked mutant presenilin 1. J Neurosci 2007, 27: 7011-7020. (Pubitemid 47015908)
23. Minoshima S, Cross D. In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008, 35(Suppl 1): S89-92.
24. Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 2008, 132: 402-416.
25. Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, McCormack GH, et al. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system. Brain Res Bull 2009, 80: 217-223.
26. Muresan V, Muresan Z. Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease? Future Neurol 2009, 4: 761-773.
27. Massaad CA, Amin SK, Hu L, Mei Y, Klann E, Pautler RG. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One 2010, 5: e10561.
28. Xiao A, Dai J. Axonal leakage is a key neuropathological change in Alzheimer's disease. Acta Med Univ Sci Technol Huazhong 2006, 35: 277-278 (in Chinese).
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34: 939-944. (Pubitemid 14076461)
30. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991, 1: 213-216.
31. Dai J, Swaab DF, Van der Vliet J, Buijs RM. Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain. J Comp Neurol 1998, 400: 87-102. (Pubitemid 28440755)
32. Erisir A, Aoki C. A method of combining biocytin tract-tracing with avidin-biotin-peroxidase complex immunocytochemistry for pre-embedding electron microscopic labeling in neonatal tissue. J Neurosci Methods 1998, 81: 189-197. (Pubitemid 28293734)
33. Nunan J, Small DH. Regulation of APP cleavage by α-, β -, and γ -secretases. FEBS Lett 2000, 483: 6-10.
34. Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, Canto I, et al. Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiol Dis 2009, 36: 11-25.
35. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 415: 720-725.
36. 2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J 1990, 9: 3539-3544.
37. Fleming LM, Johnson GV. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem J 1995, 309: 41-47.
38. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A 1991, 88: 7552-7556. (Pubitemid 21915191)
39. Rifenburg RP, Perry G. Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease. Neurodegeneration 1995, 4: 235-237.
40. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443: 787-795. (Pubitemid 44622683)
41. Muhammad S, Bierhaus A, Schwaninger M. Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease. J Alzheimers Dis 2009, 16: 775-785.
42. Salmina AB. Neuron-glia interactions as therapeutic targets in neurodegeneration. J Alzheimers Dis 2009, 16: 485-502.